Agoracom Blog

NORTHBUD $NBUD.ca – Open letter to Ottawa: This one small detail is hindering the #cannabis industry’s success $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:48 PM on Wednesday, November 20th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Open letter to Ottawa: This one small detail is hindering the cannabis industry’s success

The excise stamp on a package of cannabis. Industry leaders say these stamps unique to every province and territory are making it more expensive to produce, package and ship cannabis to individual markets.Darren Brown/Postmedia

The devil is in the details. It’s a common but important refrain. It reminds us how even the smallest facets of plans, processes and situations can derail large-scale efforts.

Such is the case facing Canada’s cannabis industry. The federal government currently requires that all cannabis products carry excise stamps — proof the appropriate taxes have been paid by the licensed producer — like those attached to tobacco packaging. These stamps are also unique to each province and territory.

Excise stamps have been a source of ongoing frustration since legalization

For such a small item, the stamp significantly complicates the business of providing legal cannabis to law-abiding consumers. In addition, excise stamps hinder the flow of legal cannabis across the country, leading to costly supply issues for both governments and consumers.

Excise stamps have been a source of ongoing frustration since legalization. The logistics of applying these stamps has resulted in unnecessary product delays. Likewise, when the industry is criticized for excessive packaging, it’s often the result of complying with federal cannabis packaging requirements, which include provincial/territorial excise stamps.

Logistics aside, the stamps hinder the industry’s long-term success. Requiring producers to use province/territory-specific excise stamps impedes the flow of product across the country. Aside from the complexity of per-province labelling, product that does not sell in one region cannot easily be transported to another province where demand may be higher. The labelling requirement removes licensed producers’ ability to respond in real time to changing demand, adds unnecessary complexity to product forecasting, and means jurisdictions and retailers face completely preventable product shortages. And when consumers can’t find what they want in the legal market, they turn to the unregulated market.

The administrative and production burdens of the stamp also mean that it’s more expensive to produce, package and ship cannabis to individual markets. This means it’s substantially tougher for legal producers and retailers to compete, particularly with respect to price, with the illegal cannabis market, which shoulders absolutely none of the costs imposed on the legal system. One of the primary goals of cannabis legalization was to compete with and thereby eliminate the unregulated market for cannabis. So why do we insist on requirements like a unique provincial/territorial excise stamp that prevents that competition?

The current system isn’t working because it ignores both business and market realities

No one is objecting to industry regulation. Licensed producers have complied with regulatory requirements related to production, distribution and promotion of the product — and have made the financial investments necessary to do so. Province- and territory-specific excise stamps, however, are costly and unnecessary when one national excise stamp would do. Especially in such a new industry, where the efficiency of the manufacturing process is paramount, it is not only counter-intuitive but also counter-productive to continue the practice.

The current system isn’t working because it ignores both business and market realities. We’re not the first industry to come to this realization. In fact, Canada’s alcohol industry moved away from province/territory-specific excise stamps years ago, after delivering its own regulatory impact analysis and successfully arguing the benefits of an alternative approach.

As an industry, we have heard consistently from both public and private retailers across Canada that the current system of unique stamps offers them little to no value. At least one territory has indicated it has asked the Canada Revenue Agency to allow it to use product excise stamps for another province in order to increase its ability to access additional supply. More importantly, CRA has indicated a willingness to work with the industry on a redesign of the excise stamp. That’s progress.

If we are wholly committed to the goals of a thriving industry, we need to alleviate the logistical, financial and environmental burden of monitoring these products while successfully competing with the unregulated market. We can do so in a way that is effective, safe, and benefits the industry as well as Canadian consumers. It’s time to excise multiple excise stamps and move, instead, to a national one.

Terry Booth, CEO, Aurora; Adine Carter, Chief Marketing Officer, Tilray; Nav Dhaliwal, CEO, The Supreme Cannabis Company; Greg Engel, CEO, Organigram; Torsten Kuenzlen, CEO, Sundial Growers; Csaba Reider, President, The Green Organic Dutchman; Irwin Simon, Interim CEO and Board Chair, Aphria; Sebastien St-Louis, President & CEO, HEXO; Mark Zekulin, CEO, Canopy Growth Corporation. The authors are members of the Cannabis Council of Canada, the national industry association representing the legal cannabis sector.

Source: https://business.financialpost.com/opinion/open-letter-to-ottawa-this-one-small-detail-is-hindering-the-cannabis-industrys-success

CLIENT FEATURE: Labrador Gold $LAB.ca: Sean Ryan Looking to Repeat Discovery Process with Labrador Gold $RIO.ca $WHM.ca $SIC.ca $NXS.ca

Posted by AGORACOM at 10:48 AM on Wednesday, November 20th, 2019
http://www.smallcapepicenter.com/LAB%20square.png
  • Labrador Gold is aggressively pursuing the under explored gold potential of Labrador.
  • 2 large, separate, under-explored land packages that demonstrate potential for district scale gold discoveries.
  • Two successful gold explorers lead the way in the Labrador gold rush: Shawn Ryan and Roger Moss.
  • 2 Key Exploration Properties: Hopedale and Ashuanipi

Hopedale:

The Hopedale property covers much of the Hunt River and Florence Lake greenstone belts that stretch over 80 km. The belts are typical of greenstone belts around the world but have been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details). Labrador Gold now controls approximately 57km strike length of the Florence Lake Greenstone Belt.

Ashuanipi:

  • Two district scale gold anomalies outlined by soil and lake sediment survey: 15x3km north south anomaly and a 14 x 3km east west anomaly
  • 2018 Soil Sampling identified: 164 samples with over 50 ppb gold, 67 samples over 100 ppb (0.1g/t) gold and a high of 8,973 ppb (8.97 g/t) Au

The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies.

LAB Agoracom Hub

FULL DISCLOSURE: Labrador Gold is an advertising client of AGORA Internet Relations Corp.

PRIMO Nutraceuticals Inc. $PRMO.ca – PODCAST: #Hemp, #CBD And #Cannabis With Josh Drayton And Alex Seleznov $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:39 AM on Wednesday, November 20th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

PODCAST: Hemp, CBD And Cannabis With Josh Drayton And Alex Seleznov

Summary

  • Josh Drayton is Communications and Outreach Director of the California Cannabis Industry Association, an association that collectively represents over 460 industry businesses.
  • Alex Seleznov is a board member and Treasurer for the National Hemp Association as well as founder of Advanced Extraction, a company specializing in organically produced hemp products.
  • They join the show today to discuss why everyone’s paying attention to California, the preventable vaping crisis and what it means to be in the current CBD space.

By Rena Sherbill

Topics include:

  • 6:45 – Josh has worked at CCIA for 4 years. Getting to know cannabis as an economic driver and way of life. Passionate about legalization.
  • 7:25 – Issues with California policy. Looking at the timeline. Legalized medical in 1996 but no state regulations. No statewide framework until 2013, which is when CCIA formed. 2016 adult use passed in California and the past few years have seen medical and adult use regulations being figured out. 55 bills in this year alone. Everyone’s paying attention to California but it takes being incredibly engaged.
  • 9:55 – Licensing supply and demand. Dual licensing system in California (local and state permits). Conflicting regulations in different areas.
  • 11:15 – Regulated vs. illicit shops. Lack of education about black market. Plays into the vaping crisis. Needs to improve. Deaths in California happened in banned areas from black market. War on drugs doesn’t improve public health. Legislators beginning to understand this.
  • 13:35 – Prediction for federal legality. Will California be a model? California modeled itself on other successful markets and has gone above and beyond in regards to packaging and testing regulations. Federal government is watching California. Canada, France, New Zealand, Germany regulators all have toured California to see how their cannabis market works. SAFE Banking Act a huge catalyst. Regulating gives more control, not less.
  • 15:23 – Farm Bill passing, CBD proliferation has helped THC market. Medical conversations help with cannabis and hemp markets.
  • 16:40 – Investors interested in getting into the space – everyone needs to understand it’s a marathon, not a sprint. The longer the legal market exists the more it’s going to pay off.
  • 17:25 – Alex’s company Advanced Extractions. Vertically integrated hemp/CBD company based in Colorado.
  • 18:25 – Confusion around passage of Farm Bill in CBD space. What it means to be in the CBD space right now. Lack of regulation means people are interpreting rules on their own. Lots of opportunity.
  • 19:49 – What do investors and consumers need to look for in this space? Investors need to vet claims a company makes. Only FDA demand is on claims. Transparency is key as well as evidence of regulatory compliance. Market is subject to scrutiny that no other product – no matter how harmful – is subject to.
  • 22:05 – Differentiation in a saturated market. Restricted marketplace gives opportunity for brands to find their niche.
  • 23:52 – Future of hemp space. Total plant purposes of hemp. Putting more renewables into the consumer stream. Alternative to plastic. Initially there will be more of a ceiling before it’s able to become a mass market product.

Source: https://seekingalpha.com/article/4307958-hemp-cbd-cannabis-josh-drayton-alex-seleznov

Empower $CBDT.ca launches #CBD product sales strategy in California and provides progress report on Heritage Joint Venture for Extraction and Production Facility in Oregon $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:39 AM on Wednesday, November 20th, 2019
  • Company has launched commissioned based sales personnel and an influencer strategy for it’s Sollievo CBD line in Southern California
  • In addition, the Heritage CSE: CANN previously announced proposed joint venture initiative, is proceeding forward as planned with the definitive agreement drafting taking place and facility and equipment procurement plans underway.

VANCOUVER, Nov. 20, 2019 - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce the Company has launched commissioned based sales personnel and an influencer strategy for it’s Sollievo CBD line in Southern California. In addition, the Heritage CSE: CANN previously announced proposed joint venture initiative, is proceeding forward as planned with the definitive agreement drafting taking place and facility and equipment procurement plans underway.

The California population is 39,557,045 people according to the US Census Bureau’s 2018 Population Estimates Program making it the most populated state in the U.S. Los Angeles County, Orange County and Ventura County have a combined population of 14,149,511 consumers making it one of the most densely populated regions of the entire country.

The California Cannabis Portal indicates there are over 170 dispensaries in Los Angeles County that our sales agents are canvassing and bringing Sollievo product samples too. They are also talking to various smoke shops, vape stores and a variety of retail locations that carry CBD products or have expressed an interest to sell CBD products.

“Establishing a retail presence in this area for our Sollievo CBD product lines gives us significant volume potential, but also provides crucial market feedback about branding, product quality and consumer adoption.” said Steven McAuley, Empowers Chairman and CEO. “Gaining direct market feedback, by having our own sales agents on the ground is already proving beneficial.”

Heritage Cannabis JV Update

  • The previously announced Empower Clinics and Heritage Cannabis JV announcement from September 17th, 2019 is continuing forward as planned with a variety of actions being completed by both Parties.

  • Documentation of the Definitive Agreement for the joint venture is underway, and progress is expected to be reported by the Companies in the near future.

  • Graeme Staley, the CEO of Purefarma and Board of Directors member for Heritage Cannabis, completed a site visit of the Sandy, OR facility located on the SE side of Portland, Oregon with Empowers Chairman & CEO Steven McAuley.

  • The site visit solidified the importance of the new 5,000 sq. ft. facility secured by Empower, and the fact that the Oregon Department of Agriculture Hemp Handlers Licence has been issued.

  • Both Empower and Heritage believe operating in a low-cost region like Oregon provides a competitive advantage with direct access to the farming supply chain for the some of the best hemp biomass in the entire country.

  • Local facility and labor costs are competitive on a national scale, and with a skilled and passionate local workforce, the joint venture has the opportunity to provide high quality long-term jobs for the local economy of Sandy, OR, Clackamas County and surrounding regions.

ABOUT EMPOWER

Empower is a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States. As a CBD product manufacturer under the Sollievo brand, the Company distributes its lines through clinics, online and through retail partners. Extraction operations are currently being developed in the Company’s new extraction facility in Oregon.

ABOUT HERITAGE

The Company is a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and BriteLife Sciences that is focused on cannabis based medical solutions. Heritage as the parent Company, is focused on providing resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empowers patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operational in 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2019/20/c5617.html

CONTACTS: Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019

INTERVIEW: Empower Clinics $CBDT.ca Bucks #Cannabis Downfall With 137% Increase In Revenue, 211% Increase In Patient Visits $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 5:10 PM on Tuesday, November 19th, 2019

Empower Clinics JV Could Generate $US 30,000,000 In Annual Revenue From CBD Extraction … But It Doesn’t End There

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Add in the fact it is now on a ~ $USD 4,000,000 annualized revenue run rate for 2019 and it becomes the kind of company small cap investors have been dying to find as they watch pretender companies melt away.

But it doesn’t end there.

The Company’s latest Q3 financials show that Empower is in full growth mode, with substantial increases in revenue and patient visits, as well as, big reductions in expenses.  Moreover, Company CEO Steven McAuley says growth will continue full steam ahead in Q4, Q1 and beyond.

But it doesn’t end there. 

CBD extraction has been a key element of the company’s vertical integration. Producing its’ own hemp-derived CBD products for its own massive patient list just makes sense. However, thanks to an LOI (moving towards definitive agreement) to JV with extraction experts Heritage Cannabis, the Company’s 5,000 sq ft facility in Oregon is also planning to serve big brand 3rd party partners in the USA .  Empower brings the infrastructure, Heritage brings the expertise and balance sheet.  The result is a match made in shareholder heaven with initial annual capacity of 6,000 Kg at ~ $US 5,000 per Kg, which adds up to $US 30,000,000 in potential revenue.

We emphasize potential  because nobody has started selling anything yet but the facility is expected to begin producing soon.  However, with a built in patient database and talks already having commenced for white label products, Empower is on its way.  Moreover, “potential” cuts both ways, with capacity capable of increasing 2x – 3x without much trouble given the size of the facility.  

Can Empower successfully execute its extraction plan?  It’s a legitimate question, with a blow away answer..
The Company’s new CEO, Steven McAuley, who replaced the previous management team in January, is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has brought Empower to such heights in just 11 months.

The cannabis market is currently throwing away babies with the bathwater – but just as the dot-com crash brought us massive riches through Web 2.0 companies that were REAL, investors need to start looking for the REAL companies that will survive and thrive.  With 165,000 patients, rapidly increasing revenues, a franchise plan to grow clinics across America and a vertical integration CBD extraction strategy to tie them all together, Empower Clinics may be such a company.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

LOMIKO Metals $LMR.ca – Installation Of The World’s First Wireless Electric Road For Trucks And Buses $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 4:10 PM on Tuesday, November 19th, 2019

SPONSOR: Lomiko Metals LMR:TSX-V – A Canadian exploration-stage company discovered high-grade graphite at its La Loutre Property in Quebec and is working toward a Pre-Economic Assessment (PEA) that will increase its current indicated resource of 4.1 Mt of 6.5% Cg to over 10 Mt of 10%+ Cg through a 21 hole program at the Refractory Zone. Click Here For More Information

The Smartroad Gotland project will today install the first section of the world’s first wireless electric road system (ERS) for trucks and buses on public roads. ERS supports electric power transfer to vehicle while in motion and have great potential to decarbonize the transport sector and to increase energy efficiency with a reduced need of batteries. Smartroad Gotland is supported and funded by the Swedish Road Administration and is led by ElectReon AB, a Swedish subsidiary of the Israeli company ElectReon Wireless. The goal of the project is to prove that ElectReon’s technology is ready for commercialization and to provide decision makers with knowledge necessary for large-scale ERS deployment.

Wireless ERS is based on coils installed below the road surface and transfer energy to a receiver that can be mounted on all types of electric vehicles such as trucks, buses, vans, and passenger cars, enabling them to charge on the go and use minimal batteries. 

The installation deployment process is simple: a 10 cm deep trench is created in the middle of the road lane in which copper coils embedded in rubber are placed and then the road is repaved with asphalt. Representatives from several countries are present on Gotland to evaluate the process as they consider a future deployment of the technology. 

The Smartroad Gotland project will start operations early 2020 with an electric truck and trailer. Before the summer the electric road will also charge and power an electric bus. Throughout the three year long project, the system performance and user experiences will be evaluated together with RISE Research Institute of Sweden. 

ElectReon has developed a unique technological design with a high efficiency suitable for both dynamic and static charing. The solution also includes a real-time communication system to ensure safety, access control, and energy metering, and which also can support autonomous vehicles. Thereby, the solution offers a smart and cost effective way of enabling a transition towards electric road transportation without any visual impacts or need for mechanical contact and heavy maintenance. 

“Today marks a very important milestone based on thorough preparations and a very dedicated team. A preparatory session was conducted on the ElectReon test site in Israel a month ago to train the team before this first deployment on public roads. I am glad that we are progressing according to plan and are now ready for Swedish climate and conditions.” â€“ HÃ¥kan Sundelin, Project Manager, Smartroad Gotland

“We are very excited to deploy our technology for a real world application for the first time after proving that it is fully functional in our test site. As part of the process we are also shifting to mass production of our coils on the way to full commercialization of our technology.” â€“ Oren Ezer, CEO, ElectReon Wireless

“So far this has been easier than we thought. It is great to be part of a project like this – the first of its kind. We are eager to learn and will bring all our best knowledge to make sure nothing goes wrong. This is an important project for Gotland, and we are happy to be part of this transition from the start.” – Dennis Silvén, COO, OSAB 

“We believe this technology has potential to become a standard for roads in the future, and we want to use our skills to take it there. NCC has experience from other ERS solutions that will benefit the construction of the smart road in Gotland. The technology has shown impressive results already.” – Stefan Hörnfeldt, affärschef eRoad, NCC Infrastructure

How it works

The system consists of three key elements; the Coil transferring energy to a Receiver on the vehicle and a Management Unit connected to the grid controlling the process. The Management Unit is connected to the electric grid and transfer energy to copper coils buried 8 cm below the lane when a valid vehicle is exactly above. The energy is wirelessly transferred from the coil to a receiver mounted underneath the vehicle. The system makes sure only valid vehicles receives energy and keeps track of how much in order to bill the right customer. A passenger car needs one receiver and a 40-ton truck would use five, but utilizing the same infrastructure.

Partners of the Smartroad Gotland project
Caverion, Dan transport, Eitech, Electreon AB, Flygbussarna, GEAB, Gotland GPe Circuit AB, Gotlands Bilfrakt, Hutchinson, Matters Group, Eksjö Maskin & Truck, Region Gotland, NCC, OSAB, RISE, Science Park Gotland, Swedavia, Trafikverket, World Ecological Forum.

https://news.cision.com/electreon-ab/r/installation-of-the-world-s-first-wireless-electric-road-for-trucks-and-buses-begins-today,c2959916

For more information, please visit www.smartroadgotland.com

North Bud Farms $NBUD.ca Enters U.S. Market with the Signing of the Definitive Agreement to Acquire Nevada Botanical Science Located in Reno, Nevada $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:59 AM on Tuesday, November 19th, 2019
  • Signed a definitive asset purchase agreement to acquire all assets of Nevada Botanical Science, Inc.
  • Transaction valued at USD$7.5 million
  • NBS currently operates a 5,000 sq. ft. indoor cultivation facility and has been approved for expansion of up to 60,000 sq. ft of greenhouse space.
  • Property also includes an operating extraction facility and licensed and approved commercial kitchen.
  • This infrastructure is capable of manufacturing and bottling beverages and edibles and is currently used by NBS for both white label and branded product manufacturing.

TORONTO, Nov. 19, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce that Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD, has signed a definitive asset purchase agreement to acquire all assets of Nevada Botanical Science, Inc. (“NBS”) (see June 25, 2019 press release) in a transaction valued at USD$7.5 million.

Nevada Botanical Science (NBS) is located in Reno, Nevada. NBS holds Nevada State medical and adult use licenses for cultivation, extraction and distribution. NBS operates an integrated cannabis operation located on 3.2 acres of land within the Reno green zone industrial park. NBS currently operates a 5,000 sq. ft. indoor cultivation facility and has been approved for expansion of up to 60,000 sq. ft of greenhouse space. The property also includes an operating extraction facility and licensed and approved commercial kitchen. This infrastructure is capable of manufacturing and bottling beverages and edibles and is currently used by NBS for both white label and branded product manufacturing. Operated by healthcare professionals, NBS has been primarily focused on the Nevada State medical cannabis market. NBS currently manufactures and sells award winning (Jack Herer Cup 2018) topical pain creams, balms and lotions under the Trichomic medical brand.

This past year NBS launched a trial release of cannabis infused cocktails under the brand “Happiest Hour”. Collaborating with local craft beverage manufactures NBS released a variety of beverages including Margarita, Pina Colada, Bloody Mary, Long Island Ice Tea and Lemonade to select retailers in the state. To date retailer adoption and reordering has been 100% and based on customer feedback, NBS will increase production and distribution including additional retailers in Las Vegas in 2020. NBS has also finished a successful trial launch of its energy shot 1oz beverage containing 25mg of THC and 50mg of Caffeine. The Company plans to run a second branded trial in early 2020. Over the past three months NBS and NORTHBUD have been working together in preparation for the release of NORTHBUD branded dried flower products in Q4 2019 and a variety of infused and non-infused pre rolls. 

“Subject to the finalizing of the previously announced acquisition of the Qlora Group in California, the Company plans to establish a unified product manufacturing and distribution platform within these two important states,” said Justin Braune, President of Bonfire Brands USA. “The license classes in California and Nevada allow for identical activities and the Company has been in negotiation with multiple potential JV partners who wish to leverage this unique platform. Being one of the few multi state operators with operations in both states will allow us to offer turnkey solutions to prospective partners moving forward.”

Transaction Terms

The transaction (the “Transaction”) is structured as an asset purchase agreement whereby in exchange for the purchase of all of the securities and assets of NBS, NORTHBUD is paying a total of USD$7,500,000 as follows:

  • Cash payment of USD$500,000 (paid in full);
  • Approximately USD$1 million in convertible shares of Bonfire Brands USA (6,500,000 “convertible shares”); and
  • A USD$6,000,000 interest bearing promissory note.

The convertible shares may be exchanged on a 1-1 basis with common shares of NBUD at the discretion of the shareholder. At the time of signing, the converted value of these securities was equal to USD$1,000,000. All applicable U.S. and Canadian regulatory holds shall apply upon conversion.

As per the terms of the agreement NBS will allocate pro rated ownership of assets in NBS and all associated licenses to Bonfire Brands USA throughout the re-payment period, subject to state approval.

Bonfire Brands and NBS have agreed to an operations and management arrangement allowing Bonfire to assume operational control, begin integration and driving revenue immediately.  

“The NORTHBUD and Bonfire Brands USA team are extremely proud to have finalized this agreement making the state of Nevada our strategic entry point into the U.S. legal cannabis market,” said Ryan Brown, CEO of NORTHBUD. “We are equally proud of the structure of the deal and how it minimizes shareholder dilution while allowing our team to begin integration and operations with a focus on immediate revenue growth in one of the most sought-after adult use markets in North America. Our team has been looking at acquisitions in Nevada for over two years before finding the right fit.  The Nevada market is considered one of the largest and most profitable in North America with recreational sales of USD$580 million in the first full year of legalization* (2017 Nevada Dept. of Taxation).”

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Transaction is a significant acquisition but will not result in a “Fundamental Change” pursuant to the policies of the CSE. NORTHBUD will be preparing the necessary corporate and securities filings in order to secure the required approvals for the Transaction.

The parties have agreed to pay USD$187,500 in broker/finder fees to arm’s length parties on a prorated basis connection with the closing of the Transaction.

The closing of the Transaction is conditional on the receipt by the parties of applicable corporate and regulatory approvals, including that of the CSE.

About Nevada Botanical Science, Inc.

Founded by a group of northern Nevada physicians and healthcare professionals who believe in the promise of medical cannabis, Nevada Botanical Science has developed a world class cannabis production, research and development facility in Reno’s Washoe County. Its work and commitment are fully in compliance with the Hippocratic Oath as well as Nevada statute. Nevada Botanical Science is dedicated to ensuring the highest measure of safety, governance and stewardship for its patients, employees and the community it serves.

For more information visit: www.nevadabotanicalscience.com

About North Bud Farms Inc.

North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has acquired Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation in Reno’s Washoe County. Nevada Botanical Science holds medical and adult use licenses for cultivation, extraction and distribution. Bonfire Brands USA has entered into an agreement to acquire assets in Salinas, California.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. This press release contains forward- looking statements including those relating to the entering into of the Definitive Agreement and closing of the Transaction with Nevada Botanical Science, Inc. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

NORTHBUD $NBUD.ca – #THC – infused #edibles and #CBD – infused edibles $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:37 PM on Monday, November 18th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

THC-infused edibles and CBD-infused edibles

When cannabis is ingested, the THC is metabolized by the liver

With edibles coming to brick-and-mortar shops in mid-December, users are looking to get high without the smoke.

But when choosing edibles, users will want to pay attention to whether the product has CBD or THC, two compounds with very different effects.

CBD

CBD, the non-psychoactive component within cannabis has been widely touted for its medical benefits to help people with, among other conditions, chronic pain. The World Health Organization (WHO) reports CBD is not physically addictive.

By comparing those administered doses of active CBD to those given as a placebo, researchers said that “while the number of studies is limited, the evidence from well-controlled human experimental research indicates that CBD is not associated with abuse potential.”

CBD leads to slower effects that aren’t psychoactive in nature — meaning they aren’t the effects you see portrayed in pop culture.

The effects from CBD will be tame and mellow compared to its psychoactive opposite, THC. Most medical cannabis includes CBD rather than THC, with CBD already available in capsule form in legal stores.

THC

When most people think of cannabis’ effects, they think of THC. Many of the new cannabis products slated to enter stores in mid-December will focus on THC.

When cannabis is ingested, the THC is metabolized by the liver, transforming itself into 11-hydroxy-THC. This metabolite is up to four times faster in crossing the blood-brain barrier than average THC, and is why edibles are associated with intense, vivid and longer-lasting experiences.

THC normally gets pointed at as the compound that creates the potential for withdrawal symptoms among some heavy users.

An evidence brief compiled by the Canadian Public Health Association (CPHA) states that “cannabis is addictive, though not everyone who uses it will develop an addiction.”

While using cannabis oil or edibles with THC, users may get addicted or experience habit-formation. Products that only include CBD don’t appear to become addictive.

Source: https://lfpress.com/cannabis-news/day-29-thc-infused-edibles-and-cbd-infused-edibles/wcm/473a4264-5028-4c42-94ca-53da8b2db7c7

Datametrex $DM.ca Reduces Senior Executives Compensation

Posted by AGORACOM-JC at 12:49 PM on Monday, November 18th, 2019
  • Senior Management including; Andrew Ryu, Jeffrey Stevens and Steve Kang have voluntarily agreed to reduce their compensation by approximately 40% effective immediately
  • Additionally, the Company’s 10% rolling stock option plan was re-approved and confirmed
  • Shareholders passed a special resolution to change the name of the Company from Datametrex AI Limited to Nexalogy AI Limited as well as a share consolidation plan of up to 8 to 1 

TORONTO, Nov. 18, 2019 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to announce that the Senior Management including; Andrew Ryu, Jeffrey Stevens and Steve Kang have voluntarily agreed to reduce their compensation by approximately 40% effective immediately. The Company also completed the integration of back office functions of Nexalogy. As a result, the Company has cut down the number of staff and office space as a part of its cost saving strategy.

“Our goal is to grow the business and share price organically rather than doing a share consolidation. The entire team is aligned with our shareholders in getting the Company back on track,” says Marshall Gunter, CEO of the Company.

The Company is also pleased to announce completion of it’s annual and special meeting.  At the meeting, Andrew Ryu, Charles Schade, Janeen Stodulski, David Ellison and John McMullen were elected as directors of the Company and KPMG were appointed as auditors for the Company.  Additionally, the Company’s 10% rolling stock option plan was re-approved and confirmed and shareholders passed a special resolution to change the name of the Company from Datametrex AI Limited to Nexalogy AI Limited as well as a share consolidation plan of up to 8 to 1. 

The Company’s name will not be changed until the Company files articles of amendment and obtains the necessary regulatory approvals.  While the resolution gives discretion to the Company’s board and management to effect the share consolidation, no decision has been made by the Company to complete the consolidation or what the consolidation ratio will be.  If and when the Company decides to implement the share consolidation, a further press release will be disseminated with the details of the share consolidation.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For further information, please contact:

Jeff Stevens – President
Phone: 647-777-7974
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

CLIENT FEATURE: Vertical Exploration $VERT.ca – Note Facility to Support Development at St-Onge Paving the Way for Wollastonite Exploitation $TORR.ca $FA.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM at 12:25 PM on Monday, November 18th, 2019
http://www.smallcapepicenter.com/Vert%20Square.png
VERT: v –

Vertical Exploration and Venturevest Realty Partners LLC have signed a non- binding Letter of Intent (LOI) to enter into discussions regarding a secured Note Facility up to a maximum amount of $20 million CAD to support the multi-phased development of the St-Onge Wollastonite Deposit.

A staged credit facility allowing Vertical to move forward with four distinct phases of St-Onge development, first establishing the initial quarry style permitting and production phase through to the mining and final processing plant stage.

https://vertxinc.com/wp-content/uploads/2018/01/Bitmap.png

What is Wollastonite?

  • Wollastonite is a chemically simple mineral named in honor of English mineralogist and chemist Sir W.H. Wollaston (1766–1828). It is composed of calcium (Ca) and silicon and oxygen (SiO2, silica) with the chemical formula CaSiO3. Although much wollastonite is relatively pure CaSiO3, it can contain some iron, magnesium, manganese, aluminum, potassium, sodium, or strontium substituting for calcium in the mineral structure. Pure wollastonite is bright white; the type and amount of impurities can produce gray, cream, brown, pale-green, or red colors.

Wollastonite’s Many Uses

Cannabis Research:

  • Wollastonite has already many well-known benefits in agriculture
  • Testing in a controlled way for the use in the cannabis industry.
  • Possibly the first in the industry to do trials.
  • Engaged AGRINOVA for Wollastonite Research and Development
  • Entered into a Distribution Agreement with AREV Brands, where Vertical will supply its St-Onge wollastonite to AREV for direct distribution to both small-scale craft growing operations and potentially larger-scale Health Canada approved companies directly involved in growing and processing cannabis and hemp.
  • Testing of Vertical’s St-Onge wollastonite on a range of important agricultural end uses will also be conducted
  • Became a member of the International Fertilizer Industry Association (IFA), as part of its ongoing efforts to promote and strategically market it’s world-class St-Onge wollastonite to a range of potential end-users.

Major Demand in Ceramics Industry:

  • Combination of high brightness and low gas release of Wollastonite when heated creates demand
  • Brilliant whiteness of importance to coatings and filler markets

Wollasatonite applications are endless

  • An industrial mineral comprised chemically of calcium, silicon and oxygen. Its molecular formula is CaSiO3 and its theoretical composition consists of 48.28% CaO and 51.72% SiO2.

St. Onge Wollastonite Deposit 2019

  • Twenty-three (23) drill holes totaling 1,784.0 metres were completed
  • Twenty (20) drill holes intersected high-grade wollastonite zones, confirming excellent continuity and correlation with the thickly mineralized zones intersected by previously reported historical drill holes.
  • Sixteen (16) drill holes intersected high-grade wollastonite zones right up until the end of the hole, which are all open at depth.
  • A total of 1,107.5 meters of high-grade wollastonite mineralized core length was intersected, representing approximately 62% of all drilled core length.